Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Importance of bioavailable calcium drinking water for the maintenance of bone mass in post-menopausal women.
Costi D, Calcaterra PG, Iori N, Vourna S, Nappi G, Passeri M. Costi D, et al. Among authors: iori n. J Endocrinol Invest. 1999 Dec;22(11):852-6. doi: 10.1007/BF03343658. J Endocrinol Invest. 1999. PMID: 10710273
Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women.
Francucci CM, Daniele P, Iori N, Camilletti A, Massi F, Boscaro M. Francucci CM, et al. Among authors: iori n. J Endocrinol Invest. 2005 Jul-Aug;28(7):623-31. doi: 10.1007/BF03347261. J Endocrinol Invest. 2005. PMID: 16218045 Clinical Trial.
Tolerability profile of SERMs.
Agnusdei D, Iori N. Agnusdei D, et al. Among authors: iori n. J Endocrinol Invest. 1999 Sep;22(8):641-5. doi: 10.1007/BF03343622. J Endocrinol Invest. 1999. PMID: 10532252 Review. No abstract available.
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S, Del Rosso A, Cinelli M, Perfetto F, Livi R, Rossi A, Gabrielli A, Giacomelli R, Iori N, Fibbi G, Del Rosso M, Cerinic MM. Guiducci S, et al. Among authors: iori n. Arthritis Res Ther. 2005;7(6):R1244-53. doi: 10.1186/ar1815. Epub 2005 Sep 8. Arthritis Res Ther. 2005. PMID: 16277677 Free PMC article.
Therapeutic potentials of androgens, estrogen and SERMs in glucocorticoid-induced osteoporosis.
Agnusdei D, Isaia GC, Iori N. Agnusdei D, et al. Among authors: iori n. Front Horm Res. 2002;30:136-44. doi: 10.1159/000061079. Front Horm Res. 2002. PMID: 11892261 Review. No abstract available.
Selective estrogen receptor modulators (SERMs): effects on multiple organ systems.
Agnusdei D, Iori N. Agnusdei D, et al. Among authors: iori n. Curr Med Chem. 2000 May;7(5):577-84. doi: 10.2174/0929867003375056. Curr Med Chem. 2000. PMID: 10702626 Review.
Raloxifene: results from the MORE study.
Agnusdei D, Iori N. Agnusdei D, et al. Among authors: iori n. J Musculoskelet Neuronal Interact. 2000 Dec;1(2):127-32. J Musculoskelet Neuronal Interact. 2000. PMID: 15758505 Free article.
Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, Agnusdei D, Iori N, Nuti R; ICARO Study Group. Adami S, et al. Among authors: iori n. J Bone Miner Res. 2006 Oct;21(10):1565-70. doi: 10.1359/jbmr.060715. J Bone Miner Res. 2006. PMID: 16995811 Free article.
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects.
Bonadonna S, Burattin A, Nuzzo M, Bugari G, Rosei EA, Valle D, Iori N, Bilezikian JP, Veldhuis JD, Giustina A. Bonadonna S, et al. Among authors: iori n. Eur J Endocrinol. 2005 Feb;152(2):199-205. doi: 10.1530/eje.1.01841. Eur J Endocrinol. 2005. PMID: 15745926 Clinical Trial.
Feedback